# PolyPid Provides Corporate Update and Reports Fourth Quarter and Full-Year 2025 Financial Results
Canonical URL: https://biopharmsignal.com/news/PYPD/polypid-provides-corporate-update-and-reports-fourth-quarter-and-full-year-2025-financial-results
Ticker: PYPD
Company: PolyPid
Source: PolyPid
Published: 2026-02-11 12:30 EST
Original Source URL: https://investors.polypid.com
## Summary

The Company is in Advanced   Stage s   of Commercial U.S.   Partner ship Discussions for D-PLEX₁₀₀ Positive FDA Pre-NDA Feedback Supports Rolling NDA Review; Submission Expected to Begin by the E nd of the First Quarter of 2026 Conference Call Scheduled for Today at 8:30 AM ET PETACH TIKVA, Israel,

## Article Body
The Company is in Advanced   Stage s   of Commercial U.S.   Partner ship Discussions for D-PLEX₁₀₀ Positive FDA Pre-NDA Feedback Supports Rolling NDA Review; Submission Expected to Begin by the E nd of the First Quarter of 2026 Conference Call Scheduled for Today at 8:30 AM ET PETACH TIKVA, Israel,
## Recent Company News
- 2026-06-01 12:30 EST — [PolyPid Completes New Drug Application Submission to FDA for D-PLEX₁₀₀](https://biopharmsignal.com/news/PYPD/polypid-completes-new-drug-application-submission-to-fda-for-d-plex) — Source: PolyPid
- 2026-05-20 12:30 EST — [PolyPid to Participate in the Craig-Hallum 23rd Annual Institutional Investor Conference](https://biopharmsignal.com/news/PYPD/polypid-to-participate-in-the-craig-hallum-23rd-annual-institutional-investor-conference) — Source: PolyPid
- 2026-05-13 11:30 EST — [PolyPid Provides Corporate Update and Reports First Quarter 2026 Financial Results](https://biopharmsignal.com/news/PYPD/polypid-provides-corporate-update-and-reports-first-quarter-2026-financial-results) — Source: PolyPid
- 2026-05-06 12:00 EST — [PolyPid to Report First Quarter 2026 Financial Results and Operational Highlights on May 13, 2026](https://biopharmsignal.com/news/PYPD/polypid-to-report-first-quarter-2026-financial-results-and-operational-highlights-on-may-13-2026) — Source: PolyPid
- 2026-04-28 12:30 EST — [PolyPid to Present Data from SHIELD II Phase 3 Trial Demonstrating Reduced Severity of Surgical Site Infection at Surgical Infection Society 2026 Annual Meeting](https://biopharmsignal.com/news/PYPD/polypid-to-present-data-from-shield-ii-phase-3-trial-demonstrating-reduced-severity-of-surgical-site-infection-at-surgical-infection-society-2026-annual-meeting) — Source: PolyPid
## Related News
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)
- 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c)
- 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)
- 2026-07-29 12:25 EST — ICCM — [IceCure: SIO Petitions NCCN to Include Cryoablation in Breast Cancer Treatment Guidelines, Citing IceCure's FDA Clearance  of ProSense®](https://biopharmsignal.com/news/ICCM/icecure-sio-petitions-nccn-to-include-cryoablation-in-breast-cancer-treatment-gu-bec46cd3)